Global Computer Aided Diagnosis (CAD) Market
Global Computer Aided Diagnosis (CAD) Market

Computer Aided Diagnosis (CAD) Comprehensive Study by Type (Breast CAD, Abdominal CAD, Prostate CAD, Chest CAD, Others), Application (Cancer {Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, & Others}, Neurological, Musculoskeletal, Cardiovascular, Others), Imaging Modality (X-Ray Imaging, Computed Tomography, Ultrasound Imaging, Magnetic Resonance Imaging, Nuclear Medicine Imaging, Others), End-User (Hospitals, Diagnostic Centers, Research Centers, Others) Players and Region - Global Market Outlook to 2025

Computer Aided Diagnosis (CAD) Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Mar 2020 Edition 222 Pages 212 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Computer Aided Diagnosis (CAD) Market Overview:
Computer-Aided Diagnosis (CAD) Forms an Important Part of the Routine Clinical Work for Detection of Diseases at Many Hospital & Screening Sites. It Helps the Radiologist to Make Final Decision About Diagnosis. It Finds Its Usage in the Detection & Differential Diagnosis of Many Different Types of Abnormalities in Medical Images Obtained in Various Examinations by Use of Different Imaging Modalities Some of the key players profiled in the study are Siemens Healthineers (Germany), IBM (United States), Hitachi High Technologies Corporation (Japan), GE Healthcare (United States), EDDA Technology, Inc. (United States), Fujifilm Holdings Corporation (Japan), Hologic Inc. (United States), iCAD, Inc. (United Kingdom) and Philips (Netherlands).

On the basis of geography, the market of Computer Aided Diagnosis (CAD) has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by , the sub-segment i.e. will boost the Computer Aided Diagnosis (CAD) market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increase in the Patients With Medical Conditions Like Cancer
  • The Rise in the Geriatric Population Globally

Market Trend
  • Increasing Usage of Artificial Intelligence Technology in Computer-Aided Diagnosis

Restraints
  • Inadequate Reimbursement Policies May Limit the Market Penetration

Opportunities
  • There is an Increased Opportunity for the Market Expansion, Owing to Surge in the Usage of CAD With Other Imaging Modalities Such as Ultrasound & Magnetic Resonance Imaging
  • There are Growing Prospects Due to Increasing Adoption of Computer-Aided Diagnosis by Radiologists in Urban as well as Rural Locations

Challenges
  • Lack of Well Qualified Operators or Technicians May Pose a Challenge




The Market for the Computer-Aided Diagnosis is Fragmented with the Presence of Many Players. Leading Players Can Adopt Strategies Like a Merger, Acquisition, Expansion, New Product Launch, in Order to Gain Share Within the Market. Owing to the Booming Healthcare Industry, there are Growing Prospects for the New Players to Enter the Market

Target Audience:
Computer-Aided Diagnosis Companies, Technology Investors, Research Institutes & Organizations, Regulatory & Government Bodies and Others

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Computer Aided Diagnosis (CAD) market on the basis of product [Breast CAD, Abdominal CAD, Prostate CAD, Chest CAD and Others] , application [Cancer {Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, & Others}, Neurological, Musculoskeletal, Cardiovascular and Others], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Computer Aided Diagnosis (CAD) market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Computer Aided Diagnosis (CAD) industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Median Technologies (France), Carestream Health (United States), ESAOTE SpA (Italy) and Riverain Technologies (United States).
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Computer Aided Diagnosis (CAD) market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.
Report Objectives / Segmentation Covered
By Type
  • Breast CAD
  • Abdominal CAD
  • Prostate CAD
  • Chest CAD
  • Others
By Application
  • Cancer {Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, & Others}
  • Neurological
  • Musculoskeletal
  • Cardiovascular
  • Others
By Imaging Modality
  • X-Ray Imaging
  • Computed Tomography
  • Ultrasound Imaging
  • Magnetic Resonance Imaging
  • Nuclear Medicine Imaging
  • Others

By End-User
  • Hospitals
  • Diagnostic Centers
  • Research Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the Patients With Medical Conditions Like Cancer
      • 3.2.2. The Rise in the Geriatric Population Globally
    • 3.3. Market Challenges
      • 3.3.1. Lack of Well Qualified Operators or Technicians May Pose a Challenge
    • 3.4. Market Trends
      • 3.4.1. Increasing Usage of Artificial Intelligence Technology in Computer-Aided Diagnosis
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Computer Aided Diagnosis (CAD), by Type, Application, Imaging Modality, End-User and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Computer Aided Diagnosis (CAD) (Value)
      • 5.2.1. Global Computer Aided Diagnosis (CAD) by: Type (Value)
        • 5.2.1.1. Breast CAD
        • 5.2.1.2. Abdominal CAD
        • 5.2.1.3. Prostate CAD
        • 5.2.1.4. Chest CAD
        • 5.2.1.5. Others
      • 5.2.2. Global Computer Aided Diagnosis (CAD) by: Application (Value)
        • 5.2.2.1. Cancer {Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, & Others}
        • 5.2.2.2. Neurological
        • 5.2.2.3. Musculoskeletal
        • 5.2.2.4. Cardiovascular
        • 5.2.2.5. Others
      • 5.2.3. Global Computer Aided Diagnosis (CAD) by: Imaging Modality (Value)
        • 5.2.3.1. X-Ray Imaging
        • 5.2.3.2. Computed Tomography
        • 5.2.3.3. Ultrasound Imaging
        • 5.2.3.4. Magnetic Resonance Imaging
        • 5.2.3.5. Nuclear Medicine Imaging
        • 5.2.3.6. Others
      • 5.2.4. Global Computer Aided Diagnosis (CAD) by: End-User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Diagnostic Centers
        • 5.2.4.3. Research Centers
        • 5.2.4.4. Others
      • 5.2.5. Global Computer Aided Diagnosis (CAD) Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Computer Aided Diagnosis (CAD): Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Siemens Healthineers (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. IBM (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Hitachi High Technologies Corporation (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GE Healthcare (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. EDDA Technology, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Fujifilm Holdings Corporation (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Hologic Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ICAD, Inc. (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Philips (Netherlands)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Computer Aided Diagnosis (CAD) Sale, by Type, Application, Imaging Modality, End-User and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Computer Aided Diagnosis (CAD) (Value)
      • 7.2.1. Global Computer Aided Diagnosis (CAD) by: Type (Value)
        • 7.2.1.1. Breast CAD
        • 7.2.1.2. Abdominal CAD
        • 7.2.1.3. Prostate CAD
        • 7.2.1.4. Chest CAD
        • 7.2.1.5. Others
      • 7.2.2. Global Computer Aided Diagnosis (CAD) by: Application (Value)
        • 7.2.2.1. Cancer {Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, & Others}
        • 7.2.2.2. Neurological
        • 7.2.2.3. Musculoskeletal
        • 7.2.2.4. Cardiovascular
        • 7.2.2.5. Others
      • 7.2.3. Global Computer Aided Diagnosis (CAD) by: Imaging Modality (Value)
        • 7.2.3.1. X-Ray Imaging
        • 7.2.3.2. Computed Tomography
        • 7.2.3.3. Ultrasound Imaging
        • 7.2.3.4. Magnetic Resonance Imaging
        • 7.2.3.5. Nuclear Medicine Imaging
        • 7.2.3.6. Others
      • 7.2.4. Global Computer Aided Diagnosis (CAD) by: End-User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Diagnostic Centers
        • 7.2.4.3. Research Centers
        • 7.2.4.4. Others
      • 7.2.5. Global Computer Aided Diagnosis (CAD) Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Computer Aided Diagnosis (CAD): by Type(USD Million)
  • Table 2. Computer Aided Diagnosis (CAD) Breast CAD , by Region USD Million (2014-2019)
  • Table 3. Computer Aided Diagnosis (CAD) Abdominal CAD , by Region USD Million (2014-2019)
  • Table 4. Computer Aided Diagnosis (CAD) Prostate CAD , by Region USD Million (2014-2019)
  • Table 5. Computer Aided Diagnosis (CAD) Chest CAD , by Region USD Million (2014-2019)
  • Table 6. Computer Aided Diagnosis (CAD) Others , by Region USD Million (2014-2019)
  • Table 7. Computer Aided Diagnosis (CAD): by Application(USD Million)
  • Table 8. Computer Aided Diagnosis (CAD) Cancer {Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, & Others} , by Region USD Million (2014-2019)
  • Table 9. Computer Aided Diagnosis (CAD) Neurological , by Region USD Million (2014-2019)
  • Table 10. Computer Aided Diagnosis (CAD) Musculoskeletal , by Region USD Million (2014-2019)
  • Table 11. Computer Aided Diagnosis (CAD) Cardiovascular , by Region USD Million (2014-2019)
  • Table 12. Computer Aided Diagnosis (CAD) Others , by Region USD Million (2014-2019)
  • Table 13. Computer Aided Diagnosis (CAD): by Imaging Modality(USD Million)
  • Table 14. Computer Aided Diagnosis (CAD) X-Ray Imaging , by Region USD Million (2014-2019)
  • Table 15. Computer Aided Diagnosis (CAD) Computed Tomography , by Region USD Million (2014-2019)
  • Table 16. Computer Aided Diagnosis (CAD) Ultrasound Imaging , by Region USD Million (2014-2019)
  • Table 17. Computer Aided Diagnosis (CAD) Magnetic Resonance Imaging , by Region USD Million (2014-2019)
  • Table 18. Computer Aided Diagnosis (CAD) Nuclear Medicine Imaging , by Region USD Million (2014-2019)
  • Table 19. Computer Aided Diagnosis (CAD) Others , by Region USD Million (2014-2019)
  • Table 20. Computer Aided Diagnosis (CAD): by End-User(USD Million)
  • Table 21. Computer Aided Diagnosis (CAD) Hospitals , by Region USD Million (2014-2019)
  • Table 22. Computer Aided Diagnosis (CAD) Diagnostic Centers , by Region USD Million (2014-2019)
  • Table 23. Computer Aided Diagnosis (CAD) Research Centers , by Region USD Million (2014-2019)
  • Table 24. Computer Aided Diagnosis (CAD) Others , by Region USD Million (2014-2019)
  • Table 25. South America Computer Aided Diagnosis (CAD), by Country USD Million (2014-2019)
  • Table 26. South America Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 27. South America Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 28. South America Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 29. South America Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 30. Brazil Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 31. Brazil Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 32. Brazil Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 33. Brazil Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 34. Argentina Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 35. Argentina Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 36. Argentina Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 37. Argentina Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 38. Rest of South America Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 39. Rest of South America Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 40. Rest of South America Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 41. Rest of South America Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 42. Asia Pacific Computer Aided Diagnosis (CAD), by Country USD Million (2014-2019)
  • Table 43. Asia Pacific Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 44. Asia Pacific Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 45. Asia Pacific Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 46. Asia Pacific Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 47. China Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 48. China Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 49. China Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 50. China Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 51. Japan Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 52. Japan Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 53. Japan Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 54. Japan Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 55. India Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 56. India Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 57. India Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 58. India Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 59. South Korea Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 60. South Korea Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 61. South Korea Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 62. South Korea Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 63. Taiwan Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 64. Taiwan Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 65. Taiwan Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 66. Taiwan Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 67. Australia Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 68. Australia Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 69. Australia Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 70. Australia Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 71. Rest of Asia-Pacific Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 72. Rest of Asia-Pacific Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 73. Rest of Asia-Pacific Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 74. Rest of Asia-Pacific Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 75. Europe Computer Aided Diagnosis (CAD), by Country USD Million (2014-2019)
  • Table 76. Europe Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 77. Europe Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 78. Europe Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 79. Europe Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 80. Germany Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 81. Germany Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 82. Germany Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 83. Germany Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 84. France Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 85. France Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 86. France Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 87. France Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 88. Italy Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 89. Italy Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 90. Italy Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 91. Italy Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 92. United Kingdom Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 93. United Kingdom Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 94. United Kingdom Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 95. United Kingdom Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 96. Netherlands Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 97. Netherlands Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 98. Netherlands Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 99. Netherlands Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 100. Rest of Europe Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 101. Rest of Europe Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 102. Rest of Europe Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 103. Rest of Europe Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 104. MEA Computer Aided Diagnosis (CAD), by Country USD Million (2014-2019)
  • Table 105. MEA Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 106. MEA Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 107. MEA Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 108. MEA Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 109. Middle East Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 110. Middle East Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 111. Middle East Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 112. Middle East Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 113. Africa Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 114. Africa Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 115. Africa Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 116. Africa Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 117. North America Computer Aided Diagnosis (CAD), by Country USD Million (2014-2019)
  • Table 118. North America Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 119. North America Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 120. North America Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 121. North America Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 122. United States Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 123. United States Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 124. United States Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 125. United States Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 126. Canada Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 127. Canada Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 128. Canada Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 129. Canada Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 130. Mexico Computer Aided Diagnosis (CAD), by Type USD Million (2014-2019)
  • Table 131. Mexico Computer Aided Diagnosis (CAD), by Application USD Million (2014-2019)
  • Table 132. Mexico Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2014-2019)
  • Table 133. Mexico Computer Aided Diagnosis (CAD), by End-User USD Million (2014-2019)
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Computer Aided Diagnosis (CAD): by Type(USD Million)
  • Table 144. Computer Aided Diagnosis (CAD) Breast CAD , by Region USD Million (2020-2025)
  • Table 145. Computer Aided Diagnosis (CAD) Abdominal CAD , by Region USD Million (2020-2025)
  • Table 146. Computer Aided Diagnosis (CAD) Prostate CAD , by Region USD Million (2020-2025)
  • Table 147. Computer Aided Diagnosis (CAD) Chest CAD , by Region USD Million (2020-2025)
  • Table 148. Computer Aided Diagnosis (CAD) Others , by Region USD Million (2020-2025)
  • Table 149. Computer Aided Diagnosis (CAD): by Application(USD Million)
  • Table 150. Computer Aided Diagnosis (CAD) Cancer {Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, & Others} , by Region USD Million (2020-2025)
  • Table 151. Computer Aided Diagnosis (CAD) Neurological , by Region USD Million (2020-2025)
  • Table 152. Computer Aided Diagnosis (CAD) Musculoskeletal , by Region USD Million (2020-2025)
  • Table 153. Computer Aided Diagnosis (CAD) Cardiovascular , by Region USD Million (2020-2025)
  • Table 154. Computer Aided Diagnosis (CAD) Others , by Region USD Million (2020-2025)
  • Table 155. Computer Aided Diagnosis (CAD): by Imaging Modality(USD Million)
  • Table 156. Computer Aided Diagnosis (CAD) X-Ray Imaging , by Region USD Million (2020-2025)
  • Table 157. Computer Aided Diagnosis (CAD) Computed Tomography , by Region USD Million (2020-2025)
  • Table 158. Computer Aided Diagnosis (CAD) Ultrasound Imaging , by Region USD Million (2020-2025)
  • Table 159. Computer Aided Diagnosis (CAD) Magnetic Resonance Imaging , by Region USD Million (2020-2025)
  • Table 160. Computer Aided Diagnosis (CAD) Nuclear Medicine Imaging , by Region USD Million (2020-2025)
  • Table 161. Computer Aided Diagnosis (CAD) Others , by Region USD Million (2020-2025)
  • Table 162. Computer Aided Diagnosis (CAD): by End-User(USD Million)
  • Table 163. Computer Aided Diagnosis (CAD) Hospitals , by Region USD Million (2020-2025)
  • Table 164. Computer Aided Diagnosis (CAD) Diagnostic Centers , by Region USD Million (2020-2025)
  • Table 165. Computer Aided Diagnosis (CAD) Research Centers , by Region USD Million (2020-2025)
  • Table 166. Computer Aided Diagnosis (CAD) Others , by Region USD Million (2020-2025)
  • Table 167. South America Computer Aided Diagnosis (CAD), by Country USD Million (2020-2025)
  • Table 168. South America Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 169. South America Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 170. South America Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 171. South America Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 172. Brazil Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 173. Brazil Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 174. Brazil Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 175. Brazil Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 176. Argentina Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 177. Argentina Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 178. Argentina Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 179. Argentina Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 180. Rest of South America Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 181. Rest of South America Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 182. Rest of South America Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 183. Rest of South America Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 184. Asia Pacific Computer Aided Diagnosis (CAD), by Country USD Million (2020-2025)
  • Table 185. Asia Pacific Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 186. Asia Pacific Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 187. Asia Pacific Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 188. Asia Pacific Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 189. China Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 190. China Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 191. China Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 192. China Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 193. Japan Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 194. Japan Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 195. Japan Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 196. Japan Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 197. India Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 198. India Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 199. India Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 200. India Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 201. South Korea Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 202. South Korea Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 203. South Korea Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 204. South Korea Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 205. Taiwan Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 206. Taiwan Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 207. Taiwan Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 208. Taiwan Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 209. Australia Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 210. Australia Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 211. Australia Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 212. Australia Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 213. Rest of Asia-Pacific Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 214. Rest of Asia-Pacific Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 215. Rest of Asia-Pacific Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 216. Rest of Asia-Pacific Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 217. Europe Computer Aided Diagnosis (CAD), by Country USD Million (2020-2025)
  • Table 218. Europe Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 219. Europe Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 220. Europe Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 221. Europe Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 222. Germany Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 223. Germany Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 224. Germany Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 225. Germany Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 226. France Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 227. France Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 228. France Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 229. France Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 230. Italy Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 231. Italy Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 232. Italy Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 233. Italy Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 234. United Kingdom Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 235. United Kingdom Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 236. United Kingdom Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 237. United Kingdom Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 238. Netherlands Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 239. Netherlands Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 240. Netherlands Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 241. Netherlands Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 242. Rest of Europe Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 243. Rest of Europe Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 244. Rest of Europe Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 245. Rest of Europe Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 246. MEA Computer Aided Diagnosis (CAD), by Country USD Million (2020-2025)
  • Table 247. MEA Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 248. MEA Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 249. MEA Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 250. MEA Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 251. Middle East Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 252. Middle East Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 253. Middle East Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 254. Middle East Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 255. Africa Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 256. Africa Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 257. Africa Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 258. Africa Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 259. North America Computer Aided Diagnosis (CAD), by Country USD Million (2020-2025)
  • Table 260. North America Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 261. North America Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 262. North America Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 263. North America Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 264. United States Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 265. United States Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 266. United States Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 267. United States Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 268. Canada Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 269. Canada Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 270. Canada Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 271. Canada Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 272. Mexico Computer Aided Diagnosis (CAD), by Type USD Million (2020-2025)
  • Table 273. Mexico Computer Aided Diagnosis (CAD), by Application USD Million (2020-2025)
  • Table 274. Mexico Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2020-2025)
  • Table 275. Mexico Computer Aided Diagnosis (CAD), by End-User USD Million (2020-2025)
  • Table 276. Research Programs/Design for This Report
  • Table 277. Key Data Information from Secondary Sources
  • Table 278. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Computer Aided Diagnosis (CAD): by Type USD Million (2014-2019)
  • Figure 5. Global Computer Aided Diagnosis (CAD): by Application USD Million (2014-2019)
  • Figure 6. Global Computer Aided Diagnosis (CAD): by Imaging Modality USD Million (2014-2019)
  • Figure 7. Global Computer Aided Diagnosis (CAD): by End-User USD Million (2014-2019)
  • Figure 8. South America Computer Aided Diagnosis (CAD) Share (%), by Country
  • Figure 9. Asia Pacific Computer Aided Diagnosis (CAD) Share (%), by Country
  • Figure 10. Europe Computer Aided Diagnosis (CAD) Share (%), by Country
  • Figure 11. MEA Computer Aided Diagnosis (CAD) Share (%), by Country
  • Figure 12. North America Computer Aided Diagnosis (CAD) Share (%), by Country
  • Figure 13. Global Computer Aided Diagnosis (CAD) share by Players 2019 (%)
  • Figure 14. Global Computer Aided Diagnosis (CAD) share by Players (Top 3) 2019(%)
  • Figure 15. Global Computer Aided Diagnosis (CAD) share by Players (Top 5) 2019(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 18. Siemens Healthineers (Germany) Revenue: by Geography 2019
  • Figure 19. IBM (United States) Revenue, Net Income and Gross profit
  • Figure 20. IBM (United States) Revenue: by Geography 2019
  • Figure 21. Hitachi High Technologies Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 22. Hitachi High Technologies Corporation (Japan) Revenue: by Geography 2019
  • Figure 23. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 24. GE Healthcare (United States) Revenue: by Geography 2019
  • Figure 25. EDDA Technology, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. EDDA Technology, Inc. (United States) Revenue: by Geography 2019
  • Figure 27. Fujifilm Holdings Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 28. Fujifilm Holdings Corporation (Japan) Revenue: by Geography 2019
  • Figure 29. Hologic Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Hologic Inc. (United States) Revenue: by Geography 2019
  • Figure 31. ICAD, Inc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. ICAD, Inc. (United Kingdom) Revenue: by Geography 2019
  • Figure 33. Philips (Netherlands) Revenue, Net Income and Gross profit
  • Figure 34. Philips (Netherlands) Revenue: by Geography 2019
  • Figure 35. Global Computer Aided Diagnosis (CAD): by Type USD Million (2020-2025)
  • Figure 36. Global Computer Aided Diagnosis (CAD): by Application USD Million (2020-2025)
  • Figure 37. Global Computer Aided Diagnosis (CAD): by Imaging Modality USD Million (2020-2025)
  • Figure 38. Global Computer Aided Diagnosis (CAD): by End-User USD Million (2020-2025)
  • Figure 39. South America Computer Aided Diagnosis (CAD) Share (%), by Country
  • Figure 40. Asia Pacific Computer Aided Diagnosis (CAD) Share (%), by Country
  • Figure 41. Europe Computer Aided Diagnosis (CAD) Share (%), by Country
  • Figure 42. MEA Computer Aided Diagnosis (CAD) Share (%), by Country
  • Figure 43. North America Computer Aided Diagnosis (CAD) Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Siemens Healthineers (Germany)
  • IBM (United States)
  • Hitachi High Technologies Corporation (Japan)
  • GE Healthcare (United States)
  • EDDA Technology, Inc. (United States)
  • Fujifilm Holdings Corporation (Japan)
  • Hologic Inc. (United States)
  • iCAD, Inc. (United Kingdom)
  • Philips (Netherlands)
Additional players considered in the study are as follows:
Median Technologies (France) , Carestream Health (United States) , ESAOTE SpA (Italy) , Riverain Technologies (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation